{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:27:47Z","timestamp":1788622067552,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["197785619"],"award-info":[{"award-number":["197785619"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["537500489"],"award-info":[{"award-number":["537500489"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["423812391"],"award-info":[{"award-number":["423812391"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023448","name":"Robert Koch Institut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"German Centre for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.molpha.2025.100069","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T23:18:04Z","timestamp":1754695084000},"page":"100069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interaction between W41 of the hepatitis B virus preS1 surface peptide and Y146\/F274 of the cellular receptor molecule Na+\/taurocholate co-transporting polypeptide is essential for virus entry"],"prefix":"10.1016","volume":"107","author":[{"given":"Sebastian","family":"Kunz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-2239","authenticated-orcid":false,"given":"Lena","family":"Soppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Leidolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7140-9933","authenticated-orcid":false,"given":"Thomas","family":"L\u00fctteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Glebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2663-1858","authenticated-orcid":false,"given":"Joachim","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2025.100069_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res"},{"issue":"24","key":"10.1016\/j.molpha.2025.100069_bib2","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1001\/jama.2023.23242","article-title":"Hepatitis D: a review","volume":"330","author":"Negro","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.molpha.2025.100069_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib4","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100069_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes","volume":"129","author":"Glebe","year":"2005","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.molpha.2025.100069_bib6","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1128\/JVI.00873-12","article-title":"Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis","volume":"86","author":"Huang","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.molpha.2025.100069_bib7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.molpha.2025.100069_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101824","article-title":"Sodium taurocholate co-transporting polypeptide deficiency","volume":"46","author":"Schneider","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"21","key":"10.1016\/j.molpha.2025.100069_bib9","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1007\/s00018-018-2892-y","article-title":"The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses","volume":"75","author":"Eller","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.molpha.2025.100069_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1515\/hsz-2022-0345","article-title":"Interactions of Na+\/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy","volume":"404","author":"Zakrzewicz","year":"2023","journal-title":"Biol Chem"},{"key":"10.1016\/j.molpha.2025.100069_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115956","article-title":"Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: opportunities for developing novel therapeutics","volume":"219","author":"Zhang","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.molpha.2025.100069_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J Hepatol"},{"issue":"15","key":"10.1016\/j.molpha.2025.100069_bib13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s40265-020-01400-1","article-title":"Bulevirtide: first approval","volume":"80","author":"Kang","year":"2020","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.molpha.2025.100069_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00103-022-03486-2","article-title":"Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect","volume":"65","author":"Nkongolo","year":"2022","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"5","key":"10.1016\/j.molpha.2025.100069_bib16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jhep.2022.06.010","article-title":"Bulevirtide with or without pegIFN\u03b1 for patients with compensated chronic hepatitis delta: from clinical trials to real-world studies","volume":"77","author":"Lampertico","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100069_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.31712","article-title":"Dual agonist of farnesoid X receptor and Takeda G protein-coupled receptor 5 inhibits hepatitis B virus infection in vitro and in vivo","volume":"74","author":"Ito","year":"2021","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.molpha.2025.100069_bib18","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1021\/acs.jmedchem.1c00078","article-title":"Design of dimeric bile acid derivatives as potent and selective human NTCP inhibitors","volume":"64","author":"Liu","year":"2021","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.molpha.2025.100069_bib19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/v13081489","article-title":"Identification of novel HBV\/HDV entry inhibitors by pharmacophore- and QSAR-guided virtual screening","volume":"13","author":"Kirstgen","year":"2021","journal-title":"Viruses"},{"issue":"23","key":"10.1016\/j.molpha.2025.100069_bib20","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.01855-15","article-title":"A novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptide","volume":"89","author":"Kaneko","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100069_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78618-2","article-title":"Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids","volume":"10","author":"Kirstgen","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/v14040764","article-title":"Fungal secondary metabolite exophillic acid selectively inhibits the entry of hepatitis B and D viruses","volume":"14","author":"Kobayashi","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.molpha.2025.100069_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2014.03.017","article-title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","volume":"106","author":"Blanchet","year":"2014","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.molpha.2025.100069_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15338-0","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jhep.2014.05.018","article-title":"Kinetics of the bile acid transporter and hepatitis B virus receptor Na+\/taurocholate cotransporting polypeptide (NTCP) in hepatocytes","volume":"61","author":"K\u00f6nig","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","article-title":"Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor","volume":"60","author":"Nkongolo","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2016.11.009","article-title":"Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity","volume":"66","author":"Shimura","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.molpha.2025.100069_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(22)01982-1","article-title":"The orally available sodium\/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitus B and D entry in vitro","volume":"77","author":"Bonn","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.molpha.2025.100069_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(23)03106-9","article-title":"FRI-231 \u2013 reduced hepatic bile acid uptake and blocked hepatitis B viral infection after oral administration of novel small molecule inhibitors of the sodium taurocholate co-transporting polypeptide (NTCP)","volume":"78","author":"Pervolaraki","year":"2023","journal-title":"J Hepatol"},{"issue":"7916","key":"10.1016\/j.molpha.2025.100069_bib30","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41586-022-04845-4","article-title":"Structure of the bile acid transporter and HBV receptor NTCP","volume":"606","author":"Asami","year":"2022","journal-title":"Nature"},{"issue":"7916","key":"10.1016\/j.molpha.2025.100069_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41586-022-04723-z","article-title":"Structural basis of sodium-dependent bile salt uptake into the liver","volume":"606","author":"Goutam","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molpha.2025.100069_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41422-022-00680-4","article-title":"Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res"},{"issue":"7916","key":"10.1016\/j.molpha.2025.100069_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41586-022-04857-0","article-title":"Structural insights into the HBV receptor and bile acid transporter NTCP","volume":"606","author":"Park","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2025.100069_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41594-023-01191-5","article-title":"Structural basis of hepatitis B virus receptor binding","volume":"31","author":"Asami","year":"2024","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100069_bib35","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/s41467-024-46706-w","article-title":"Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.molpha.2025.100069_bib36","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/v14061259","article-title":"Tyrosine 146 of the human Na+\/taurocholate cotransporting polypeptide (NTCP) is essential for its hepatitis B virus (HBV) receptor function and HBV entry into hepatocytes","volume":"14","author":"Zakrzewicz","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.molpha.2025.100069_bib37","first-page":"1330","article-title":"Validation of NBD-coupled taurocholic acid for intravital analysis of bile acid transport in liver and kidney of mice","volume":"23","author":"Ghallab","year":"2024","journal-title":"EXCLI J"},{"issue":"11","key":"10.1016\/j.molpha.2025.100069_bib38","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1021\/acs.jmedchem.5c00589","article-title":"Fluorescent 4-nitrobenzo-2-oxa-1,3-diazole-coupled bile acids as probe substrates of hepatic and intestinal bile acid transporters of the solute carrier families SLC10 and SLCO","volume":"68","author":"Drossel","year":"2025","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.molpha.2025.100069_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199200","article-title":"Characterisation of the hepatitis B virus cross-species transmission pattern via Na+\/taurocholate co-transporting polypeptides from 11 New World and Old World primate species","volume":"13","author":"M\u00fcller","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/v14040727","article-title":"IFITM3 interacts with the HBV\/HDV receptor NTCP and modulates virus entry and infection","volume":"14","author":"Palatini","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.molpha.2025.100069_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12539-015-0263-z","article-title":"Conformational preferences of \u03c0-\u03c0 stacking between ligand and protein, analysis derived from crystal structure data geometric preference of \u03c0-\u03c0 interaction","volume":"7","author":"Zhao","year":"2015","journal-title":"Interdiscip Sci"},{"issue":"8","key":"10.1016\/j.molpha.2025.100069_bib42","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","article-title":"Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition","volume":"279","author":"Ho","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100069_bib43","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014889","article-title":"A clinically relevant polymorphism in the Na+\/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position","volume":"296","author":"Ruggiero","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2025.100069_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijid.2019.01.038","article-title":"NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases","volume":"80","author":"Binh","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.molpha.2025.100069_bib45","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gutjnl-2015-310686","article-title":"The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B","volume":"65","author":"Hu","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib46","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.27608","article-title":"The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B","volume":"61","author":"Peng","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molpha.2025.100069_bib47","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.molpha.2025.100069_bib48","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide","volume":"88","author":"Yan","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100069_bib49","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1038\/s41467-024-53533-6","article-title":"Structural basis for hepatitis B virus restriction by a viral receptor homologue","volume":"15","author":"Shionoya","year":"2024","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.molpha.2025.100069_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00938-21","article-title":"NTCP oligomerization occurs downstream of the NTCP-EGFR interaction during hepatitis B virus internalization","volume":"95","author":"Fukano","year":"2021","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.molpha.2025.100069_bib51","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/JVI.03540-12","article-title":"Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide","volume":"87","author":"Yan","year":"2013","journal-title":"J Virol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25153297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25153297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:42:47Z","timestamp":1772829767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25153297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0026895X25153297"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100069","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction between W41 of the hepatitis B virus preS1 surface peptide and Y146\/F274 of the cellular receptor molecule Na+\/taurocholate co-transporting polypeptide is essential for virus entry","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100069"}}